ACE inhibitors(Angiotensin-converting enzyme inhibitors), COX inhibitors(Cyclooxygenases inhibitors), HMG-CoA reductase inhibitors(HMG-CoA reductase inhibitors)

+ [1]

Therapeutic Areas

Cardiovascular Diseases

Active Indication

Cardiovascular Diseases

Inactive Indication-

Originator Organization

Alborz Darou Pharmaceutical Co.

Active Organization

Alborz Darou Pharmaceutical Co.

Inactive Organization-

Drug Highest PhaseApproved

First Approval Date

IR (01 Feb 2018),

Cardiovascular Diseases

Regulation-

Structure

Molecular FormulaC66H76CaF2N4O13

InChIKeyHIZONJHAVINWOX-NIJVSVLQSA-N

CAS Registry344423-98-9

View All Structures (4)

External Link

KEGG	Wiki	ATC	Drug Bank
-	-	C03AX01	-

R&D Status

10 top approved records.

to view more data

Indication	Country/Location	Organization	Date
Cardiovascular Diseases	IR	Alborz Darou Pharmaceutical Co.	01 Feb 2018

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis